GG-818

• Description :

  GG-818 (GW 1818) is a potent and selective α1 adrenoceptor antagonist, with pKi values of 9.7 for α1a, 7.8 for α1b, and 7.6 for α1d. GG-818 (GW 1818) can be used for benign prostatic hyperplasia research[1].

• Product Name Alternative :

  GW 1818

• UNSPSC :

  12352005

• Target :

  Adrenergic Receptor

• Related Pathways :

  GPCR/G Protein; Neuronal Signaling

• Applications :

  Metabolism-protein/nucleotide metabolism

• Field of Research :

  Metabolic Disease

• Smiles :

  O=S(C1=CC(CCN2CCC(C3=NC(COCC(F)(F)F)=C(C4=CC=C(F)C=C4)O3)CC2)=CC=C1OC)(N)=O

• Molecular Formula :

  C26H29F4N3O5S

• Molecular Weight :

  571.58

• References & Citations :

  [1]Kenny B, et al. Pharmacological options in the treatment of benign prostatic hyperplasia. J Med Chem. 1997 Apr 25;40 (9) :1293-315.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported

• Isoform :

  α adrenergic receptor

• CAS Number :

  [179535-60-5]